Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
52,067,388
-
Share change
-
+2,431,569
-
Total reported value
-
$5,738,610,992
-
Put/Call ratio
-
198%
-
Price per share
-
$110.34
-
Number of holders
-
371
-
Value change
-
+$276,047,323
-
Number of buys
-
174
-
Number of sells
-
200
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q2 2020
As of 30 Jun 2020,
Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by
371 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,067,388 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, LSV ASSET MANAGEMENT, AQR CAPITAL MANAGEMENT LLC, JPMORGAN CHASE & CO, FMR LLC, STATE STREET CORP, Nuveen Asset Management, LLC, and CITADEL ADVISORS LLC.
This page lists
375
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.